Hep B in Blood Transfusions; Ultraprocessed Foods and IBD; The Microbiome and CRC

Experts in JAMA Pediatrics warned of the risk of hepatitis B virus transmission via transfusions for infants who rely on blood products and do not receive the hepatitis B vaccine birth dose.

Findings from a terminated randomized trial in the early phase of acute pancreatitis found that a high-energy strategy for early nutrition, compared with gradually increasing energy, did not reduce mortality and may increase the risk of organ failure. (Gut)

Researchers looked at the use of intestinal ultrasound for predicting therapy response in Crohn’s disease. (Inflammatory Bowel Diseases)

Lower intake of ultraprocessed food was significantly linked with a lower inflammatory bowel disease (IBD) risk at 20 years, a propensity-matched analysis of a large multinational prospective cohort study found. (Gastroenterology)

In a phase III trial, darvadstrocel failed to improve remission rates versus placebo in Crohn’s disease patients with complex perianal fistulas. (Gastroenterology)

Meanwhile, retrospective data backed oral vancomycin as a potential disease-modifying therapy for IBD patients with primary sclerosing cholangitis. (Gastro Hep Advances)

Fecal calprotectin appears to be accurate as a noninvasive screening tool for pouchitis, according to an analysis of prospective single-center data. (Inflammatory Bowel Diseases)

Administration of intravenous albumin in Veterans with cirrhosis following outpatient paracentesis was associated with a lower risk of hospitalization for acute kidney injury in a retrospective cohort study. (Hepatology)

Researchers in Gut suggested that gut microbiome changes linked to colorectal cancer (CRC) may occur because of the cancer development rather than be the cause of it.